Login / Signup

Tumor Stroma Ratio and Its Significance in Locally Advanced Colorectal Cancer.

Luz SullivanRichard R PachecoMichel KmeidAnne ChenHwajeong Lee
Published in: Current oncology (Toronto, Ont.) (2022)
Colorectal cancer is the third leading cause of cancer-related death, and its incidence is rising in the younger patient population. In the past decade, research has unveiled several processes (underlying tumorigenesis, many of which involve interactions between tumor cells and the surrounding tissue or tumor microenvironment (TME). Interactions between components of the TME are mediated at a sub-microscopic level. However, the endpoint of those interactions results in morphologic changes which can be readily assessed at microscopic examination of biopsy and resection specimens. Among these morphologic changes, alteration to the tumor stroma is a new, important determinant of colorectal cancer progression. Different methodologies to estimate the proportion of tumor stroma relative to tumor cells, or tumor stroma ratio (TSR), have been developed. Subsequent validation has supported the prognostic value, reproducibility and feasibility of TSR in various subgroups of colorectal cancer. In this manuscript, we review the literature surrounding TME in colorectal cancer, with a focus on tumor stroma ratio.
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • clinical trial
  • neoadjuvant chemotherapy
  • case report
  • study protocol
  • ultrasound guided
  • phase ii study